Shocking New Trial to Test Pacemakers on Brains of Alzheimer’s Patients
Patients are still being recruited for the new study started by researchers at Functional Neuromodulation in Toronto. DBS treatment for Alzheimer’s has already been tested in a pilot program involving six patients who had their brains stimulated constantly for one year. These patients showed signs of increased neuron activity.
The glucose metabolism of the brain of an Alzheimer’s patient is diminished in the area believed to deal with memory. The patients in the pilot study showed a slight increase of glucose consumption in that region of the brain.
Researchers admit the findings are only a small step, but believe any avenue with promising results is worth exploring further. Assistant professor of neurology at Baylor College of Medicine in Houston Michele York said:
Alternative treatment strategies need to be evaluated in Alzheimer’s disease due to the numerous recent failures of drug trials to halt or stave off cognitive decline in this population. The surgery could provide a new avenue for treatment for this debilitating and progressive disorder.
The new study will implant DBS devices that will either be active or inactive into patients, who through brain scans and doctor’s observations, will be studied for a year. The hypothesis is that the electrical activity caused by the device could stimulate critical parts of the brain. They hope this could slow or reduce the atrophy of brain tissue associated with the disease.
(via Tehcnology Review, image via Nathaniel Burton-Bradford)
Relevant to your interests
- Gene associated with dementia could make you clever in your youth
- The zebra fish can regrow its brain
- Birth control pills could increase women’s cognitive abilities later in life
Have a tip we should know? tips@themarysue.com
